- Home
- ARCT vs EQV Comparison
ARCT vs EQV Comparison
Compare ARCT & EQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- EQV
- Stock Information
- Founded
- ARCT 2013
- EQV 2024
- Country
- ARCT United States
- EQV United States
- Employees
- ARCT N/A
- EQV N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- EQV
- Sector
- ARCT Health Care
- EQV
- Exchange
- ARCT Nasdaq
- EQV Nasdaq
- Market Cap
- ARCT 526.5M
- EQV 463.6M
- IPO Year
- ARCT N/A
- EQV 2024
- Fundamental
- Price
- ARCT $10.59
- EQV $10.43
- Analyst Decision
- ARCT Buy
- EQV
- Analyst Count
- ARCT 10
- EQV 0
- Target Price
- ARCT $35.25
- EQV N/A
- AVG Volume (30 Days)
- ARCT 2.1M
- EQV 50.7K
- Earning Date
- ARCT 11-07-2025
- EQV 01-01-0001
- Dividend Yield
- ARCT N/A
- EQV N/A
- EPS Growth
- ARCT N/A
- EQV N/A
- EPS
- ARCT N/A
- EQV N/A
- Revenue
- ARCT $122,122,000.00
- EQV N/A
- Revenue This Year
- ARCT N/A
- EQV N/A
- Revenue Next Year
- ARCT $34.32
- EQV N/A
- P/E Ratio
- ARCT N/A
- EQV $50.95
- Revenue Growth
- ARCT N/A
- EQV N/A
- 52 Week Low
- ARCT $8.04
- EQV $9.91
- 52 Week High
- ARCT $24.17
- EQV $10.74
- Technical
- Relative Strength Index (RSI)
- ARCT 31.16
- EQV 65.45
- Support Level
- ARCT $9.19
- EQV $10.40
- Resistance Level
- ARCT $12.10
- EQV $10.43
- Average True Range (ATR)
- ARCT 1.78
- EQV 0.03
- MACD
- ARCT -1.35
- EQV 0.00
- Stochastic Oscillator
- ARCT 9.36
- EQV 94.12
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About EQV EQV Ventures Acquisition Corp.
EQV Ventures Acquisition Corp is a blank check company.